	Tumor immune microenvironment in non-small cell lung cancer progression. Front Immunol Jiang J, Zhong M, Wang J, Zhang Z, Li W, Deng Z. PMID: 42233035 [PubMed - in process]
	Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy. Front Immunol May P, Winter C, Hubrecht I, Patenge A, Strathmeyer S, Geyer R, Heelemann S, Stratmann J, Safi S, Klein H, Schneller F, Bassermann F, Becker von Rose A. PMID: 42233027 [PubMed - in process]
	Perioperative outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer: a meta-analysis focusing on real-world clinical studies in the past 10 years. Front Oncol Zhu J, Meng X, Hu L. PMID: 42232542 [PubMed]
	Techniques of double-sleeve lobectomy for lung cancer: a narrative review of clinical practice. J Vis Surg Nameghi FH, Aresu G, Peryt A, Coonar AS. PMID: 42232282 [PubMed]
	Comment On: "Association Between Admission Prognostic Nutritional Index and Pulmonary Infection Status in Hospitalized Lung Cancer Patients: A Retrospective Cohort Study" [Letter]. J Inflamm Res Dan Q. PMID: 42232157 [PubMed]
	Uniportal video-assisted thoracoscopic surgery segmentectomy for early-stage non-small cell lung cancer: indications and surgical technique. J Vis Surg Suzuki J, Watanabe H, Takamori S, Uchida T, Shiono S. PMID: 42232042 [PubMed]
	Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study. Thorac Cancer Yamauchi K, Matsumoto K, Shiroyama T, Tamiya A, Tamiya M, Tsukaguchi A, Miyazaki A, Komuta K, Mihashi Y, Machiyama H, Kanaoka K, Kuge T, Kinehara Y, Shoshihara N, Niki T, Kato S, Nishikawa Y, Azuma K, Tanaka S, Osa A, Suzuki H, Nagatomo I, Uchida J, Takeda Y, Kumanogoh A. PMID: 42231603 [PubMed - in process]
	Mechanism study of RUNX1/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer. Respir Res He C, Li Y, He H, Zhou F, Fu B, Bu J, Wang M, Kong X, Li P, Ni B, Xu S. PMID: 42231351 [PubMed - as supplied by publisher]
	Prospective germline exome and machine learning-based risk score identify predictive and prognostic biomarkers of immunotherapy outcomes in advanced non-small cell lung cancer. J Transl Med González-Hernández A, Ríos A, Onieva JL, Cantero A, Rivero-Aguilar M, Paz-López G, Rueda-Domínguez A, Garrido-Barros M, Martínez-Gálvez B, Zafra J, Figueroa-Ortiz LC, Pérez-Ruiz E, Benítez JC, Barragán I, Oliver J. PMID: 42231301 [PubMed - as supplied by publisher]
	Large scale evaluation of a multiple tumor marker panel for lung cancer diagnosis and histological subtyping. Discov Oncol Geng J, Li L, Li J, Cao T, Zhou J, Sheng W, Guo H. PMID: 42231004 [PubMed - as supplied by publisher]
	Solasonine suppresses non-small cell lung cancer progression by inhibiting the STAT3/PD-L1 axis. Sci Rep Zheng L, Song Q, Liang J. PMID: 42230729 [PubMed - as supplied by publisher]
	The application of rapid ultrasound-guided paraffin technique in the pathological examination of biopsy specimens from non-small cell lung cancer. Sci Rep Zhu LH, Yang JR, Xia WX, Qiu YL, Ye XZ, Qi XF. PMID: 42230693 [PubMed - as supplied by publisher]
	Lipid Metabolic Reprogramming in Lung Cancer: Mechanisms and Therapeutic Targets in the Tumor Microenvironment. Int J Cancer Wang S, Yu J. PMID: 42230155 [PubMed - as supplied by publisher]
	Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project. J Thorac Oncol Dacic S, Shenker D, Redman M, Brunner L, Saqi A, Cooper WA, Borczuk A, Chung JH, Glass C, Lopez JM, Roden AC, Sholl L, Weissferdt A, Brosnan-Cashman J, Hennek S, Grullon S, Posadas J, Fujimoto J, Connolly C, Wynes MW, Sanchez-Espiridion B, Lee JJ, Berezowska S, Chou TY, Kerr K, Nicholson AG, Schalper KA, Tsao MS, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn PA Jr, Kris MG, Travis W, Yu L, Wistuba I, IASLC Pathology Committee. PMID: 42229633 [PubMed - as supplied by publisher]
	[What matters most? Quality of life preferences in lung cancer care treatment from the perspective of patients and physicians - A Systematic Review]. Gesundheitswesen Friebel S, Ibler K, Emmert M. PMID: 42229444 [PubMed - as supplied by publisher]
	Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis. Lung Cancer Wang J, Takundwa R, Yang H, Chai X, Yu Y, Zhang Y, Dirnberger F, Anderson ES, Pastel M, Pundole X, Gomez-Randulfe I, Blackhall F. PMID: 42229339 [PubMed - as supplied by publisher]
	Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis. Lung Cancer Liu WH, Cheng YJ, Kang J, Chen J, An ZJ, Li TH, Tan N, Zhong WZ, Wu YL, Jiang L. PMID: 42229338 [PubMed - as supplied by publisher]
	Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study. Jpn J Clin Oncol Ji NN, Yang XY, Xiao SQ, Zhao N, Su WL, Xu JN, Shao L, Li SN, Zeng YC. PMID: 42228854 [PubMed - as supplied by publisher]
	Fibroblast activation protein inhibitor-PET/CT in lung cancer: a prospective single-center study with histopathological correlation of fibroblast activation protein expression. Int J Clin Oncol Hiroshima T, Kimura T, Watabe T, Matsui T, Omura A, Sugiura Y, Nagata H, Kimura K, Fukui E, Kanou T, Ose N, Tatsumi M, Giesel FL, Morii E, Shintani Y. PMID: 42228299 [PubMed - as supplied by publisher]
	Prognostic impact of weight loss during first-line chemotherapy in extensive-disease small cell lung cancer. Support Care Cancer Fujisaki T, Naito T, Kumaki S, Kataoka S, Saito S, Matsuda S, Kobayashi H, Ko R, Wakuda K, Ono A, Murakami H, Takahashi T, Kenmotsu H. PMID: 42228208 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159186

Page 1 of 7960



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy